Canopy Growth Q2 Fiscal Year 2025 Financial Results Revealed
Storz & Bickel experienced a notable 32% rise in net revenue during the second quarter of the fiscal year 2025. This increase reflects the sustained expansion seen in their medical cannabis enterprises. The company’s financial performance in Q2 FY2025 demonstrates significant progress and success in their operations within the cannabis industry.
